Other studies support the hypothesis of a shared mechanism between WD and CIPN, since both vincristine (VCR) and bortezomib (BTZ) activate a common SARM1–dependent axon degeneration pathway [73]. The gene discussed is SARM1; the disease is Wilson disease.